{{Rsnum
|rsid=8373
|Gene=ZFP91
|Chromosome=11
|position=58610951
|Orientation=plus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.2222
|Gene_s=ZFP91,ZFP91-CNTF
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.2 | 36.3 | 11.5
| HCB | 61.9 | 32.1 | 6.0
| JPT | 67.0 | 30.4 | 2.7
| YRI | 66.4 | 29.5 | 4.1
| ASW | 70.2 | 26.3 | 3.5
| CHB | 61.9 | 32.1 | 6.0
| CHD | 78.5 | 20.6 | 0.9
| GIH | 58.0 | 33.0 | 9.0
| LWK | 60.2 | 33.3 | 6.5
| MEX | 67.2 | 31.0 | 1.7
| MKK | 54.5 | 38.5 | 7.1
| TSI | 58.0 | 33.0 | 9.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=8373
|allele=G
|frequency=
|uid=1103649697352
|type=heterozygous_SNP
|hugo=ZFP91
|ensembl gene=ENSG00000186660
|ensembl transcript=ENST00000316059
|sift=AFFECT FUNCTION
|disease=Overexpressed in most acute myelogenous leukemia (AML) cases (27 over 29).
}}

{{PMID|16400609|OA=1
}} Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.

{{GET Evidence
|gene=ZFP91
|aa_change=Ser207Gly
|aa_change_short=S207G
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8373
|overall_frequency_n=2252
|overall_frequency_d=10758
|overall_frequency=0.209333
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.949
|nblosum100=2
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}